194 related articles for article (PubMed ID: 31557402)
1. ALPK1 regulates streptozotocin-induced nephropathy through CCL2 and CCL5 expressions.
Lee CP; Nithiyanantham S; Hsu HT; Yeh KT; Kuo TM; Ko YC
J Cell Mol Med; 2019 Nov; 23(11):7699-7708. PubMed ID: 31557402
[TBL] [Abstract][Full Text] [Related]
2. Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells.
Haberstroh U; Pocock J; Gómez-Guerrero C; Helmchen U; Hamann A; Gutierrez-Ramos JC; Stahl RA; Thaiss F
Kidney Int; 2002 Oct; 62(4):1264-76. PubMed ID: 12234296
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy.
Mezzano S; Aros C; Droguett A; Burgos ME; Ardiles L; Flores C; Schneider H; Ruiz-Ortega M; Egido J
Nephrol Dial Transplant; 2004 Oct; 19(10):2505-12. PubMed ID: 15280531
[TBL] [Abstract][Full Text] [Related]
4. Enhanced alpha-kinase 1 accelerates multiple early nephropathies in streptozotocin-induced hyperglycemic mice.
Kuo TM; Hsu HT; Chung CM; Yeh KT; Wu CT; Lee CP; Chiang SL; Huang CM; Ko YC
Biochim Biophys Acta; 2016 Nov; 1862(11):2034-2042. PubMed ID: 27542954
[TBL] [Abstract][Full Text] [Related]
5. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
[TBL] [Abstract][Full Text] [Related]
6. Endogenous NAMPT dampens chemokine expression and apoptotic responses in stressed tubular cells.
Benito-Martin A; Ucero AC; Izquierdo MC; Santamaria B; Picatoste B; Carrasco S; Lorenzo O; Ruiz-Ortega M; Egido J; Ortiz A
Biochim Biophys Acta; 2014 Feb; 1842(2):293-303. PubMed ID: 24287278
[TBL] [Abstract][Full Text] [Related]
7. C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration.
Rudemiller NP; Patel MB; Zhang JD; Jeffs AD; Karlovich NS; Griffiths R; Kan MJ; Buckley AF; Gunn MD; Crowley SD
Am J Pathol; 2016 Nov; 186(11):2846-2856. PubMed ID: 27640148
[TBL] [Abstract][Full Text] [Related]
8. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
[TBL] [Abstract][Full Text] [Related]
9. Chemokine MCP1/CCL2 and RANTES/CCL5 gene polymorphisms influence Henoch-Schönlein purpura susceptibility and severity.
Yu HH; Liu PH; Yang YH; Lee JH; Wang LC; Chen WJ; Chiang BL
J Formos Med Assoc; 2015 Apr; 114(4):347-52. PubMed ID: 25839768
[TBL] [Abstract][Full Text] [Related]
10. Innate signaling mechanisms controlling Mycobacterium chelonae-mediated CCL2 and CCL5 expression in macrophages.
Kim YS; Kim JH; Woo M; Kim TS; Sohn KM; Lee YH; Jo EK; Yuk JM
J Microbiol; 2015 Dec; 53(12):864-74. PubMed ID: 26626357
[TBL] [Abstract][Full Text] [Related]
11. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.
Bursill CA; Castro ML; Beattie DT; Nakhla S; van der Vorst E; Heather AK; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1773-8. PubMed ID: 20702809
[TBL] [Abstract][Full Text] [Related]
12. Ashwagandha attenuates TNF-α- and LPS-induced NF-κB activation and CCL2 and CCL5 gene expression in NRK-52E cells.
Grunz-Borgmann E; Mossine V; Fritsche K; Parrish AR
BMC Complement Altern Med; 2015 Dec; 15():434. PubMed ID: 26667305
[TBL] [Abstract][Full Text] [Related]
13. Effect of retinoic acid in experimental diabetic nephropathy.
Han SY; So GA; Jee YH; Han KH; Kang YS; Kim HK; Kang SW; Han DS; Han JY; Cha DR
Immunol Cell Biol; 2004 Dec; 82(6):568-76. PubMed ID: 15550114
[TBL] [Abstract][Full Text] [Related]
14. Suppressive effects of antimycotics on tumor necrosis factor-alpha-induced CCL27, CCL2, and CCL5 production in human keratinocytes.
Kanda N; Watanabe S
Biochem Pharmacol; 2006 Aug; 72(4):463-73. PubMed ID: 16784723
[TBL] [Abstract][Full Text] [Related]
15. CCL2 conditionally determines CCL22-dependent Th2-accumulation during TGF-β-induced breast cancer progression.
Mandal PK; Biswas S; Mandal G; Purohit S; Gupta A; Majumdar Giri A; Roy Chowdhury S; Bhattacharyya A
Immunobiology; 2018 Feb; 223(2):151-161. PubMed ID: 29107385
[TBL] [Abstract][Full Text] [Related]
16. CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice.
El-Hage N; Bruce-Keller AJ; Knapp PE; Hauser KF
J Neuroimmune Pharmacol; 2008 Dec; 3(4):275-85. PubMed ID: 18815890
[TBL] [Abstract][Full Text] [Related]
17. Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages.
Skwor TA; Cho H; Cassidy C; Yoshimura T; McMurray DN
J Leukoc Biol; 2004 Dec; 76(6):1229-39. PubMed ID: 15377675
[TBL] [Abstract][Full Text] [Related]
18. ALPK1 affects testosterone mediated regulation of proinflammatory cytokines production.
Kuo TM; Yeh KT; Hsu HT; Chiang SL; Chang JG; Huang CM; Tu HP; Liu CS; Ko YC
J Steroid Biochem Mol Biol; 2015 Nov; 154():150-8. PubMed ID: 26275947
[TBL] [Abstract][Full Text] [Related]
19. Suppression of NF-kappaB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor.
Wang XC; Jobin C; Allen JB; Roberts WL; Jaffe GJ
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):477-86. PubMed ID: 9950608
[TBL] [Abstract][Full Text] [Related]
20. IL-33 stimulates human mast cell release of CCL5 and CCL2 via MAPK and NF-κB, inhibited by methoxyluteolin.
Bawazeer MA; Theoharides TC
Eur J Pharmacol; 2019 Dec; 865():172760. PubMed ID: 31669588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
